Skip to content
DE

Inulin powder

Clinical review pending

Inulin is a fermentable fiber that feeds gut bacteria. Which effects have been studied, and why the dose matters for how well you tolerate it.

Editorial draft after language editing and an evidence check. Final clinical sign-off is still pending.

Inulin from chicory root: what makes a prebiotic

Inulin is a plant fructan: it consists mostly of linked fructose units and may carry a glucose unit at the end of the chain. Sources include chicory root, Jerusalem artichoke, garlic and onions, and other plants contain fructans in varying amounts too. Human digestive enzymes cannot break its characteristic bonds. In the large intestine, bacteria can ferment the inulin. Study

FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols. Inulin and related fructans belong to the fermentable carbohydrates that can trigger symptoms in sensitive people. Being a fermentable fiber and a possible FODMAP trigger at the same time is not a contradiction: both properties come from the way bacteria process it in the gut. Study

Fructan polymers: the degree of polymerization matters

Chain length is given as the degree of polymerization (DP). Native chicory inulin is a mixture with DP 2–60. Oligofructose consists mainly of shorter chains, while long-chain inulin is obtained by an extra separation step. Native inulin is therefore not the same thing as a purely long-chain fraction. Chain length, amount and the bacteria already present in your gut all influence fermentation, but none of this reliably predicts how much gas a particular product will produce in you. Study

From chicory-root food enrichment to dietary supplement

Chicory root (Cichorium intybus) is an important commercial source. Fructans also occur in many everyday foods. Inulin was studied as a food ingredient and prebiotic long before today’s interest in gut health. Study Study

How inulin actually feeds your gut bacteria

Inulin serves as food for certain gut bacteria and can, among other things, increase bifidobacteria. These produce mainly acetate and lactate, and other bacteria can process those intermediates further, for example into butyrate. Some of the resulting metabolites are absorbed by the body. A shift in the bacterial profile on its own does not prove a noticeable health benefit. Mechanistic study

Selective fermentation and SCFA production

Fermentation is a joint effort of many different bacteria. Short-chain fatty acids can supply gut cells with energy and take part in metabolic and immune processes. Animal studies show such mechanisms, but they do not allow direct conclusions about disease prevention in humans. Human studies on calcium absorption have their own findings, which differ by population. The fatty acid response is not uniform either: in a small crossover study it did not rise after inulin, even though certain bacterial taxa increased. Study Study Study Study

Gut transit, fermentation rate and gas production

Inulin is not absorbed in the small intestine the way sugar is, but the products of its bacterial breakdown can enter the body’s metabolism. Shorter chains are often available for fermentation more quickly. That does not mean they can be pinned to one specific section of the colon, or that long-chain products are guaranteed to cause less bloating. Tolerance also depends on the dose, the rest of your diet and your individual gut bacteria. Starting slowly can help, but persistent symptoms should not simply be accepted as a necessary adjustment phase.

Assessing the claims about inulin

The evidence base for inulin has an unusual shape. Claims about its prebiotic effect and bowel regularity are reasonably well supported by human trial data. But the same rapid fermentation that drives these benefits is exactly what triggers fullness, gas and abdominal discomfort in people with irritable bowel syndrome. In other words, the same compound works in opposite directions depending on who takes it.

  • Strong: ≥2 well-designed human RCTs on a clinically meaningful endpoint, ideally with a meta-analysis showing a consistent direction of effect. Or a single very large RCT (N>1,000) with replicable methods.

  • Moderate: ≥1 human RCT with a clinically meaningful endpoint, OR several smaller RCTs with mixed results, OR a single high-quality RCT on a surrogate endpoint.

  • Limited: only small (N<50), short (<8 weeks) or methodologically weak human studies, or only observational evidence in humans.

  • Animal / preclinical only: no completed human trials. Only in vitro, animal model or phase 1 safety data.

  • Anecdotal: no controlled evidence of any kind: case reports, testimonials, mechanistic plausibility or marketing claims not backed by published data.

Inulin can increase stool frequency: Moderate

For native chicory inulin, EFSA (the European Food Safety Authority) has accepted an increase in stool frequency at a daily intake of 12 g. That is a specific statement about bowel function, not a sweeping treatment recommendation for every form of chronic constipation. A recent review of dietary fibers looked mostly at people with normal bowel function and found small to moderate effects that varied from fiber to fiber. EFSA Study

Inulin can increase bifidobacteria: Moderate

Bifidobacteria rise in several studies, even though the other microbial changes vary. A six-week study found changes in individual metabolites, and a small crossover study found an increase in Bifidobacterium and Anaerostipes. Neither automatically means greater diversity or better health. The overall evidence on inflammation and immune effects of different prebiotics is inconsistent. Study Study Study

Inulin and calcium absorption: Limited

Human evidence that inulin-type fructans influence calcium absorption is clearest in adolescents; in adults the results are less consistent. A one-year randomized controlled trial looked at this in pubertal adolescents. They took 8 grams a day of a mixed short- and long-chain inulin-type fructan. Compared with placebo, they absorbed considerably more calcium. They also gained more whole-body bone mineral content and bone mineral density. This is the most direct human evidence that the effect translates into measurable changes in bone. Notably, the benefit appeared during the window of active skeletal mineralization. Short-term tracer studies in young adults showed where this happens. Among the people analyzed whose absorption responded to the preparation, most of the extra absorption took place in the colon. That selection does not allow a statement about all adults. In adults and postmenopausal women, the evidence is thinner and more mixed. A small crossover study gave oligofructose-enriched inulin to women after menopause. It increased both calcium and magnesium absorption. Another crossover trial used short-chain fructooligosaccharides instead. It found no overall change in calcium absorption. A recent study tested adults with type 2 diabetes. It found no effect on calcium status or bone turnover markers. The proposed mechanism is biologically plausible: short-chain fatty acids lower the pH in the colon. Even so, confirming data on bone status in adults at supplement doses remain limited. Source link 1 Source link 2 Source link 3 Source link 4 Source link 5

Inulin may slightly influence metabolic markers (LDL-C, glycemia, hs-CRP): Limited

The six-week study mainly examined metabolites in blood and stool. On its own, it does not show a clinically relevant drop in LDL, HbA1c or hs-CRP. Positive findings for yacon flour also cannot be fully transferred to pure inulin, because yacon flour contains other components. In a small inulin study, glucose and insulin stayed unchanged. Any possible metabolic benefit therefore has to be judged for the specific product, dose and group of people. Study Study Study

Inulin replaces neither the treatment of a metabolic disease nor a varied diet. With irritable bowel syndrome, the picture is nuanced: fructans can trigger symptoms, yet a review of inulin-containing mixed foods reported better quality of life in IBS with constipation. That does not prove a benefit of pure inulin for everyone with IBS, but it does argue against a blanket ban. Study Study

Short-chain vs. long-chain: what changes in the colon

Inulin products differ by origin and chain length. These features help when comparing products, but they do not replace an individual judgment of how well you tolerate them.

  • Native chicory inulin. Contains a mixture of shorter and longer chains. For precisely specified native inulin, the European claim on stool frequency is tied to 12 g a day; that is not a suitable starting dose for everyone.

  • Short-chain fructans / FOS. Oligofructose contains mainly shorter chains and can be derived from inulin. There are also FOS made in other ways. The terms describe related products that are not identical in every respect.

  • Agave fructans. Their structure can differ from chicory inulin. The same product name or similar gram amounts therefore do not guarantee an identical effect.

  • GOS, PHGG and resistant starch. These are different fibers with their own studies and properties. GOS can also promote bifidobacteria. None of this supports a general ranking by “best” bacteria or least gas.

When comparing products, look at the exact ingredient list, the amount per serving and, where available, a traceable certificate of analysis. Quality testing can cover composition or contaminants; it does not prove any health effect.

Check whether the product is pure inulin or a blend. In a blend, the total weight does not necessarily equal the amount of inulin. An additive such as ordinary maltodextrin is not the same as resistant maltodextrin; the two behave differently in digestion.

Which health claims are permitted

Under its published labeling practice, the FDA allows inulin and inulin-type fructans to be counted as dietary fiber on Nutrition Facts labels. This food-law classification is not a drug approval. FDA

In the EU, following a scientific assessment by EFSA, a health claim on normal bowel function through increased stool frequency was authorized. It applies to a more closely defined native chicory inulin at a daily intake of 12 g. The authorization is granted by the European Commission, not by EFSA itself. EU regulation EFSA

Safety, tolerance and the FODMAP tension

At typical supplement doses, inulin has a generally favorable safety record. Tolerance, however, depends on the dose and the population. For people with irritable bowel syndrome or FODMAP sensitivity, the very fermentation that makes inulin a useful prebiotic for healthy people is what makes it a documented symptom trigger.

Fullness, gas and the tolerance curve

Gas, abdominal discomfort and changes in stool consistency are among the possible side effects. Starting with a small amount and only increasing it if you tolerate it well makes more sense than taking the full product serving right away. A fixed adjustment period cannot be promised. In a small reintroduction study in people who had previously responded to a low-FODMAP diet, fructans and GOS made abdominal pain worse. That applies to this selected group and not automatically to everyone with IBS. Study

Interactions with medications: mostly indirect, mostly gastrointestinal

  • Oral medications. A general spacing interval that applies to all medicines has not been established for inulin. Follow the instructions for each medication, and ask a pharmacist if you are unsure.

  • Antibiotics. They can change the gut microbiome. That alone justifies neither taking extra inulin nor a particular time gap.

  • Iron supplements, low. Preclinical data suggest inulin may modulate liver ferritin; clinical relevance for the timing of oral iron intake in humans has not been established. Source link

  • Diabetes medications. Inulin does not replace blood-sugar-lowering treatment. Coordinate larger dietary changes with your existing therapy.

The fact that intact inulin is not absorbed does not prove that every indirect interaction is ruled out. Full pharmacological safety cannot be inferred from the nutrition studies cited here.

Pregnancy, breastfeeding and groups who need extra caution

Fructan-containing foods are part of a normal diet during pregnancy and breastfeeding as well. That does not yield a universally valid dose for targeted inulin supplementation. For children, people with inflammatory bowel disease, marked motility disorders or persistent symptoms, suitability should be assessed individually. IBS or suspected SIBO on its own is not a sufficiently justified blanket contraindication, but it can be a reason to pay particular attention to tolerance. Study Study

When inulin is unsuitable without professional guidance

In the following situations, an individual consultation makes sense. Not every one of them means inulin is ruled out altogether:

  • IBS during a FODMAP-reduction phase: inulin may conflict with the diet plan. During later reintroduction, your personal tolerance is what counts. Study

  • Suspected or diagnosed SIBO: persistent symptoms need professional assessment. The IBS studies cited here do not support any SIBO-specific recommendation on inulin.

  • During an active flare of inflammatory bowel disease: discuss additional fiber with your treating practice.

  • Severe gastroparesis or marked motility disorders: the diet should be tailored to the specific condition.

  • Documented hypersensitivity to inulin or chicory, rare but reported; people allergic to chicory may experience cross-reactions.

  • Pregnancy and breastfeeding, when taking supplemental doses without medical supervision; controlled data on these doses are lacking.

  • Children: studies on added fiber do not replace an individual, age-appropriate dosing recommendation.

If any of the points above applies to you, do not start taking this supplement without talking to a doctor or a registered dietitian who knows your full medical context.

Inulin vs. FOS, GOS, PHGG and resistant starch

The practical question is not only “Does inulin work?” but also “Is inulin the right prebiotic fiber for this person?” The answer depends heavily on gastrointestinal tolerance, the main goal and whether FODMAP sensitivity is present.

  • Source and chemistry. Inulin and FOS are related fructans. GOS are galacto-oligosaccharides, PHGG is partially hydrolyzed guar gum, and resistant starch escapes digestion in the small intestine.

  • Fermentation. The various fibers are processed differently. The product, the dose and the bacteria present in the gut all help determine which metabolites are formed.

  • Effect supported in practice. For native chicory inulin, increased stool frequency is recognized. For IBS, guidelines tend to recommend carefully chosen soluble fibers such as psyllium husk; the various preparations are not interchangeable. EFSA NICE

  • Doses. Studies vary considerably. For example, 8 g of a fructan blend was studied in adolescents for calcium absorption, and 16 g in adults with type 2 diabetes. A dose from a study is not a personal regimen. Study Study

  • Tolerance. A blanket ranking from “best” to “worst” fiber has not been established. What matters is whether bowel movements and symptoms actually improve with the product you choose.

  • Cost. Compare the cost per amount of fiber actually contained; prices differ by product and supplier.

  • Product status. Fibers can be food ingredients or dietary supplements. Being sold in either category does not prove effectiveness against any disease.

If your main goal is more regular bowel movements and you tolerate fructans, inulin is one option to consider. With IBS, it is worth choosing a fiber deliberately together with a qualified nutrition professional. A symptom diary is more practical for this than trying to derive the ideal fiber from a commercial microbiome profile. NICE Consensus

Which measurements can show changes

For otherwise healthy people, a trial of inulin does not require extra blood or microbiome tests. What matters in practice are stool frequency, consistency, abdominal discomfort and tolerance. Lab values have their place when there is a specific condition or diagnostic question.

  • hs-CRP: a nonspecific marker of inflammation, not reliable evidence of an individual effect of inulin.

  • HbA1c: used to assess blood sugar over the longer term. A change cannot be attributed to a single fiber alone.

  • Fasting insulin: not an established routine test for measuring the benefit of an inulin product.

  • LDL-C: part of assessing cardiovascular risk when that question is relevant. An extra test just because of inulin is not justified.

  • Fecal calprotectin: can help in the workup or monitoring of inflammatory bowel disease. It is not a general test of the gut barrier or of prebiotic success.

  • Microbiome tests: commercial profiles are currently not supported well enough to serve as a routine basis for such dietary decisions. Consensus

Before and while taking it, note how your bowel movements and symptoms develop. These observations can help you decide whether to keep taking the product. They are not controlled proof of efficacy, and extra lab tests do not automatically solve that problem.

When gut symptoms deserve clinical attention

Inulin powder is a prebiotic fiber supplement, not a diagnostic tool and not a treatment for gastrointestinal disease. If the reason someone reaches for inulin is chronic constipation that has not responded to dietary changes, persistent unexplained bloating, rectal bleeding or unintended weight loss, those symptoms call for a gastroenterological evaluation before any supplement is introduced. Taking supplements first for unexplained symptoms can delay the diagnostic workup that is needed.

If IBS is suspected, the first step is a medical assessment of the symptoms. A low-FODMAP diet is a possible further step if general dietary and lifestyle advice is not enough. It should be done with professional guidance and followed by individual reintroduction, so that the diet does not stay unnecessarily restricted. NICE Study

Persistent or worsening symptoms are a reason to get checked, not a reason to keep raising the inulin dose.

Frequently asked questions

What is inulin powder?

Inulin is a plant-based, fermentable fiber. It occurs in chicory root, Jerusalem artichoke, garlic and onions, among other foods. Gut bacteria can process it, and certain groups of bacteria increase as a result. Broader microbiome diversity is not a guaranteed effect. Study

Does inulin powder actually work?

Inulin can increase stool frequency and boost bifidobacteria. Whether you benefit also depends on how well you tolerate it. On calcium absorption, there are positive human studies in adolescents and in some adult groups, but also studies showing no effect. None of this amounts to an established treatment for osteoporosis. Study Study Study

What inulin doses have been used in studies?

The dose depends on the product and the purpose of the study: the EU claim on stool frequency refers to 12 g of native chicory inulin a day. Other studies used, for example, 8 g of a fructan blend in adolescents or 16 g in adults with type 2 diabetes. Do not automatically start with a study dose; tolerance is what counts. EU regulation Study Study

What are the side effects of inulin powder?

Possible side effects include gas, abdominal pain and changes in stool. Fructans can trigger symptoms especially in people with FODMAP sensitivity. Getting worse is not inevitable for every person with IBS, though. Study

Is inulin powder FDA-approved?

The FDA includes inulin and inulin-type fructans in its published practice for fiber labeling; that is not a drug approval. In the EU, a precisely defined claim on stool frequency is authorized for 12 g of native chicory inulin a day. FDA EU regulation

How does inulin compare with other prebiotic fibers such as FOS and psyllium?

Inulin and FOS are related, readily fermentable fructans. Psyllium husk has different properties and is named in guidelines as a soluble fiber for IBS. GOS, PHGG and resistant starch are further options with their own data; no single fiber is optimal for everyone. NICE

Who should avoid inulin powder?

During a FODMAP-reduction phase, inulin usually does not fit the plan. If you are allergic to the specific ingredient, avoid it. In pregnancy, while breastfeeding, for children or with a bowel condition that needs treatment, targeted supplemental doses should be discussed individually. A blanket ban for everyone with IBS is not justified.

Which blood tests should I have done before trying inulin?

A trial of inulin on its own usually does not call for extra blood tests. If you have symptoms or known conditions, your treating practice decides which tests make sense. Commercial microbiome profiles currently do not offer sufficiently validated guidance on an individual inulin dose. Consensus

Sources and literature

  • Roberfroid MB (2007). Inulin-type fructans: functional food ingredients. The Journal of nutrition, 137(11 Suppl), 2493S-2502S. https://doi.org/10.1093/jn/137.11.2493S

  • Raninen K, Lappi J, Mykkänen H, Poutanen K (2011). Dietary fiber type reflects physiological functionality: comparison of grain fiber, inulin, and polydextrose. Nutrition reviews, 69(1), 9-21. https://doi.org/10.1111/j.1753-4887.2010.00358.x

  • Roberfroid MB (2000). Fructo-oligosaccharide malabsorption: benefit for gastrointestinal functions. Current opinion in gastroenterology, 16(2), 173-7. https://doi.org/10.1097/00001574-200003000-00013

  • Yu Y, He J, Fu H, Mi Y, Wu H, Gao Y, Li M (2025). Inulin Modulates Gut Microbiota and Increases Short-Chain Fatty Acids Levels to Inhibit Colon Tumorigenesis in Rat Models: A Systematic Review and Meta-Analysis. Journal of food science, 90(5), e70250. https://doi.org/10.1111/1750-3841.70250

  • Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ (2005). A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. The American Journal of Clinical Nutrition, 82(2), 471-476. https://doi.org/10.1093/ajcn/82.2.471

  • Abrams SA, Hawthorne KM, Aliu O, Hicks PD, Chen Z, Griffin IJ (2007). An inulin-type fructan enhances calcium absorption primarily via an effect on colonic absorption in humans. The Journal of Nutrition, 137(10), 2208-2212. https://doi.org/10.1093/jn/137.10.2208

  • Holloway L, Moynihan S, Abrams SA, Kent K, Hsu AR, Friedlander AL (2007). Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. British Journal of Nutrition, 97(2), 365-372. https://doi.org/10.1017/S000711450733674X

  • Tahiri M, Tressol JC, Arnaud J, Bornet FRJ, Bouteloup-Demange C, Feillet-Coudray C, Brandolini M, Ducros V, Pepin D, Brouns F, Roussel AM, Rayssiguier Y, Coudray C (2003). Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: A stable-isotope study. The American Journal of Clinical Nutrition, 77(2), 449-457. https://doi.org/10.1093/ajcn/77.2.449

  • Birkeland E, Bamigbetan WA, Molven KD, Thorsby PM, Gulseth HL, Aas, A.-M., Dahl C (2025). Can supplements with prebiotic fibres positively influence bone health in type 2 diabetes? Insights from a randomised controlled crossover trial. Archives of Osteoporosis, 20(1), 71. https://doi.org/10.1007/s11657-025-01556-x

  • Chen L, Avendano EA, Valdes-Valderrama A, Lan JL, Tye D, Morin RA, Staffier KA, McKeown NM, Nirmala N (2024). Physiologic Effects of Isolated or Synthetic Dietary Fiber in Children: A Scoping Review. Current developments in nutrition, 8(2), 102074. https://doi.org/10.1016/j.cdnut.2023.102074

  • Siragusa N, Baldassari G, Ferrario L, Passera L, Rota B, Pavan F, Santagata F, Capasso M, Londoni C, Manfredi G, Consalvo D, Lasagni G, Pozzi L, Lombardo V, Mascaretti F, Scricciolo A, Roncoroni L, Elli L, Vecchi M, Costantino A (2025). The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications. Nutrients, 17(15). https://doi.org/10.3390/nu17152496

  • Deng X, Liang C, Zhou L, Shang X, Hui X, Hou L, Wang Y, Liu W, Liang S, Yao L, Yang K, Li X (2024). Network meta-analysis of probiotics, prebiotics, and synbiotics for the treatment of chronic constipation in adults. European journal of nutrition, 63(6), 1999-2010. https://doi.org/10.1007/s00394-024-03410-1

  • Balk EM, Couch E, Mai HJ, Chen Y, Adam GP, Kanaan G, Caputo EL, Trikalinos TA, Williams G, Duncanson K, Talley NJ, Lichtenstein AH (2026). Fiber intake and laxation in people with normal bowel function: a systematic review. The American journal of clinical nutrition, 123(3), 101212. https://doi.org/10.1016/j.ajcnut.2026.101212

  • Arioz Tunc H, Calder PC, Cait A, Dodd GF, Gasaly Retamal NYI, Guillemet D, James D, Korzeniowski KJ, Lubkowska A, Meynier A, Ratajczak W, Respondek F, Thabuis C, Vaughan EE, Venlet N, Walton G, Gasser O, de Vos P (2026). Impact of non-digestible carbohydrates and prebiotics on immunity, infections, inflammation and vaccine responses: a systematic review of evidence in healthy humans and a discussion of mechanistic proposals. Critical reviews in food science and nutrition, 66(1), 1-74. https://doi.org/10.1080/10408398.2025.2514700

  • Kouraki A, Nogal A, Nocun W, Louca P, Vijay A, Wong K, Michelotti GA, Menni C, Valdes AM (2024). Machine Learning Metabolomics Profiling of Dietary Interventions from a Six-Week Randomised Trial. Metabolites, 14(6). https://doi.org/10.3390/metabo14060311

  • Silva IFD, Bragante WR, Junior RCM, Laurindo LF, Guiguer EL, Araújo AC, Fiorini AMR, Nicolau CCT, Oshiiwa M, Lima EP, Barbalho SM, Silva LR (2024). Effects of Smallanthus sonchifolius Flour on Metabolic Parameters: A Systematic Review. Pharmaceuticals (Basel, Switzerland), 17(5). https://doi.org/10.3390/ph17050658

  • Mou J, Xu L, Luo Y, Tao Q, Wang Z, Chen M, Zheng H (2025). Assessing the Efficacy of Functional Food as Treatment for Irritable Bowel Syndrome with Constipation: A Systematic Review and Network Meta-Analysis. Nutrition reviews. https://doi.org/10.1093/nutrit/nuaf204

  • Cuffe MS, Staudacher HM, Aziz I, Adame EC, Krieger-Grubel C, Madrid AM, Ohlsson B, Black CJ, Ford AC (2025). Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis. The lancet. Gastroenterology & hepatology, 10(6), 520-536. 00054-8). https://doi.org/10.1016/S2468-1253(25)00054-8

  • Eswaran S, Jencks KJ, Singh P, Rifkin S, Han-Markey T, Chey WD (2025). All FODMAPs Aren’t Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 23(2), 351-358.e5. https://doi.org/10.1016/j.cgh.2024.03.047

  • Singh P, Chey SW, Nee J, Eswaran S, Dietary Therapy in IBS Working Group, Lembo A, Chey WD (2025). Is a Simplified, Less Restrictive Low FODMAP Diet Possible? Results From a Double-Blind, Pilot Randomized Controlled Trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 23(2), 362-364.e2. https://doi.org/10.1016/j.cgh.2024.04.021

  • Zhao X, He W, Jakobsen LMA, Zachariassen LF, Hansen AK, Rasmussen MK, Bertram HC (2023). Inulin Supplementation Modulates the Hepatic Transcriptome, Metabolome, and Ferritin Content in Ovariectomized Rats. Molecular nutrition & food research, 67(23), e2300372. https://doi.org/10.1002/mnfr.202300372

  • Bartsch M, Vital M, Woltemate S, Bouwman FG, Berkemeyer SB, Hahn A, Müller M (2025). Microbiota-Dependent Fiber Responses: A Proof-of-Concept Study on Short-Chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals. The Journal of nutrition, 155(11), 3809-3822. https://doi.org/10.1016/j.tjnut.2025.08.034

  • EFSA. Native chicory inulin and stool frequency. https://www.efsa.europa.eu/en/efsajournal/pub/3951

  • European Commission. Regulation 2015/2314. https://eur-lex.europa.eu/eli/reg/2015/2314/oj/eng

  • FDA. Dietary fiber declaration guidance. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-declaration-certain-isolated-or-synthetic-non-digestible-carbohydrates-dietary

  • NICE. Irritable bowel syndrome recommendations. https://www.nice.org.uk/guidance/CG61/chapter/recommendations

  • International consensus statement on microbiome testing in clinical practice. https://pmc.ncbi.nlm.nih.gov/articles/PMC12343204/

  • Moens F, Verce M, De Vuyst L (2017). Lactate- and acetate-based cross-feeding interactions between selected strains of lactobacilli, bifidobacteria and colon bacteria in the presence of inulin-type fructans. https://doi.org/10.1016/j.ijfoodmicro.2016.10.019

  • Roberfroid et al. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. https://pubmed.ncbi.nlm.nih.gov/12468594/

Origin and editorial review status

Adapted from the source article and checked against accessible studies, guidelines and professional information. Final clinical sign-off is still pending; the draft remains excluded from indexing.